CLEVER LEAVES HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.11 USD | +6.14% |
|
+0.72% | +96.23% |
| 04-26 | Clever Leaves to Delist Securities From Nasdaq | MT |
| 04-01 | Clever Leaves Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 17.8 1.43K | Sales 2023 | 17.42 1.39K | Capitalization | 3.66M 293M |
|---|---|---|---|---|---|
| Net income 2022 | -66M -5.28B | Net income 2023 | -17M -1.36B | EV / Sales 2022 | 445,103 x |
| Net cash position 2022 | 8.59M 688M | Net cash position 2023 | 4.74M 380M | EV / Sales 2023 | -62,512 x |
| P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-0.18
x | Employees | 296 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clever Leaves Holdings Inc.
More recommendations
More press releases
| 1 day | +6.14% | ||
| 1 week | +0.72% | ||
| Current month | -15.61% | ||
| 1 month | -16.12% | ||
| 3 months | +51.66% | ||
| 6 months | +82.67% | ||
| Current year | +96.23% |
1 week
3.59
4.45
1 month
3.595.89
Current year
2.005.89
1 year
1.728.95
3 years
1.72372.00
5 years
1.72583.81
10 years
1.72583.81
| Managers | Title | Age | Since |
|---|---|---|---|
Andrés Fajardo
CEO | Chief Executive Officer | 46 | 31/12/18 |
Henry Hague
DFI | Director of Finance/CFO | 52 | 21/02/21 |
Julián Wilches
LAW | General Counsel | 45 | 17/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gary M. Julien
BRD | Director/Board Member | 54 | 17/12/20 |
| Director/Board Member | 69 | 17/12/20 | |
| Chairman | 54 | 31/01/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.28% | 35 M€ | +18.97% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 4.11 | +6.14% | 200,570 |
| 25/04/24 | 3.872 | -1.47% | 4,162 |
| 24/04/24 | 3.93 | +1.29% | 6,065 |
| 23/04/24 | 3.88 | +1.17% | 4,137 |
| 22/04/24 | 3.835 | -6.02% | 9,569 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
Sector
Pharmaceuticals
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.11
Average target price
-
| 1st Jan change | Capi. | |
|---|---|---|
| +96.23% | 7.21M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- CLVR Stock
